Table 7.
Results for base-case scenario
| Placebo | Treatment | Difference (treatment vs. placebo) |
|
|---|---|---|---|
| ICER, USD | 344,425 | ||
| Cost outcomes, USD | |||
| Total cost | 181,123 | 196,519 | 15,396 |
| Care cost | 181,123 | 171,815 | (9,308) |
| Drug cost | 0 | 24,703 | 24,703 |
| Health outcomes | |||
| Patient QALYs | 3.73 | 3.77 | 0.045 |
| Patient life-years | 5.64 | 5.64 | 0 |
| Caregiver QALYs | 3.60 | 3.61 | 0.01 |
| Psychiatric medication use, years | |||
| Time on psychiatric medication | 4.42 | 4.18 | (0.24) |
| Time on antipsychotics | 1.18 | 1.18 | (0.002) |
| Time on antidepressants | 2.63 | 2.44 | (0.19) |
| Time on anxiolytics | 1.78 | 1.72 | (0.05) |
| Residential care, % | 30 | 28 | (2) |
| Time in residential care, years | 1.57 | 1.52 | (0.05) |
| Mortality, % | 77 | 77 | 0 |
ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.